Synlogic, Inc. (SYBX)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $1.05
- As of
Kresmion compiles this page from SYBX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
SYNLOGIC, INC. (SYBX): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-11.
See the full SYBX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for SYBX on one page. Preview it with sample data, then open it live with a free account.
Preview the SYBX dossierActive events for SYBX
- mediumEarnings above estimates
Q4-2024: Beat consensus by 41.2% - EPS $-0.06 vs $-0.102 estimate
- mediumEarnings below estimates
Q1-2024: Missed consensus by 210.9% - EPS $-2.6 vs $-0.8364 estimate
- mediumEarnings above estimates
Q2-2024: Beat consensus by 130.8% - EPS $0.16 vs $-0.5202 estimate
- mediumEarnings above estimates
Q3-2024: Beat consensus by 94.6% - EPS $-0.01 vs $-0.1836 estimate
- mediumEarnings above estimates
Beat consensus by 41.2% - EPS $-0.06 vs $-0.102 estimate
FREE, NO ACCOUNT
Every event on SYBX, as it fires
New filings, 13F moves and cross asset events on SYBX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Historical quarters remain available above.
Recent SEC filings, SYBX
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-QSEC EDGAR ↗
SYBX against its peers
SYBX's return on equity of -8.5% ranks in the 97th percentile of 15 Biotechnology sub-industry peers, fiscal periods ending between 2025-06-30 and 2026-06-30.
| Metric | SYBX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 0.0 USD | 710968 USD | 12 | 12 |
| Revenue YoY | -100.0% | n/a | n/a | 1 |
| Gross margin | n/a | 71.3% | n/a | 5 |
| Operating margin | n/a | -1151.0% | n/a | 10 |
| Net margin | n/a | -1120.7% | n/a | 10 |
| Return on equity | -8.5% | -214.9% | 97 | 15 |
Peers (21): TCRX, AAGH, ACTU, DARE, HEPA, BIVI, ASBP, ICU, ADIL, KTTA, CNSY, RKTO, AEON, CKDXF, LPCN, HIND, BCDA, INTI, KPTI, TVRD, GUTS. Left out: VICP (period gap), RADX (no annual filing), CTXR (no annual filing), HOOK.D (period gap). Fiscal periods ending between 2025-06-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (SYBX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow SYBX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to SYBX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.